Newsroom
October 14, 2024
Jennifer Sharpe Potter, PhD, MPH, vice president for research, professor of psychiatry and behavioral sciences and founding director of the Be Well Institute on Substance Use and Related Disorders, was quoted in this article. Read More (subscription required)
September 30, 2024
Charles P. France, PhD, to lead methocinnamox drug development program The University of Texas Health Science Center at San Antonio (UT Health San Antonio) was awarded a $12 million cooperative agreement (U01) from the National Institutes of Health’s National Institute on Drug Abuse to further develop methocinnamox (MCAM) as a treatment for opioid use disorder. […]
August 29, 2024
Curtis Bone, MD, MHS, departments of Psychiatry and Behavioral Sciences and Family and Community Medicine, and board-certified addiction medicine physician at the Be Well Institute on Substance Use and Related Disorders, was interviewed for this article. Watch Now
August 29, 2024
Curtis Bone, MD, MHS, departments of Psychiatry and Behavioral Sciences and Family and Community Medicine, and board-certified addiction medicine physician at the Be Well Institute on Substance Use and Related Disorders, was interviewed for this article. Read More
August 27, 2024
Kenneth M. Hargreaves, DDS, PhD, is a world-renowned expert in pain research Kenneth M. Hargreaves, DDS, PhD, professor of endodontics at the School of Dentistry of The University of Texas Health Science Center at San Antonio (UT Health San Antonio), has been named inaugural director of the school’s Center for Pain Therapeutics and Addiction Research. Hargreaves, who chaired the […]
August 20, 2024
Lack of oxygen can sensitize nerve cells, leading to long-term pain More than 100 million people worldwide are affected by obstructive sleep apnea. This health condition causes a person to stop breathing numerous times while they are sleeping. Reduced sleep time and sleep quality can lead to numerous health problems including obesity, high blood pressure, […]
